| [1] |
RIEDHAMMER K M, NGUYEN T T, KOSUKCU C, et al. Implication of transcription factor FOXD2 dysfunction in syndromic congenital anomalies of the kidney and urinary tract (CAKUT)[J]. Kidney Int,2024,105(4):844-864.doi:10.1016/j.kint. 2023. 11.032 .
doi: 10.1016/j.kint. 2023. 11.032
|
| [2] |
MUNTEAN C, CHIRTES C, BACZONI B, et al. PAX2 Gene Mutation in Pediatric Renal Disorders-A Narrative Review[J]. Int J Mol Sci,2023,24(16).doi:10.3390/ijms241612737 .
doi: 10.3390/ijms241612737
|
| [3] |
SCHIERBAUM L M, SCHNEIDER S, BUERGER F, et al. Prioritization of Monogenic Congenital Anomalies of the Kidney and Urinary Tract Candidate Genes with Existing Single-Cell Transcriptomics Data of the Human Fetal Kidney[J]. Nephron Clin Pract,2023,147(11):685-692.doi:10.1159/000531770 .
doi: 10.1159/000531770
|
| [4] |
LASZCZYK A M, HIGASHI A Y, PATEL S R, et al. Pax2 and Pax8 Proteins Regulate Urea Transporters and Aquaporins to Control Urine Concentration in the Adult Kidney[J]. J Am Soc Nephrol,2020,31(6):1212-1225.doi:10.1681/ASN. 2019090962 .
doi: 10.1681/ASN. 2019090962
|
| [5] |
LIU J L, WANG X W, LIU C H, et al. Genetic spectrum of CAKUT and risk factors for kidney failure: A pediatric multicenter cohort study[J]. Nephrol Dial Transplant,2022,38(9):1981-1991.doi:10.1093/ndt/gfac338 .
doi: 10.1093/ndt/gfac338
|
| [6] |
BINGUL I, KALAYCI R, TEKKESIN M S, et al. Chenodeoxycholic acid alleviated the cyclosporine-induced nephrotoxicity by decreasing oxidative stress and suppressing renin-angiotensin system through AT2R and ACE2 mRNA upregulation in rats[J]. J Mol Histol,2024,56(1):23.doi:10.1007/s10735-024-10308-z .
doi: 10.1007/s10735-024-10308-z
|
| [7] |
PALEVSKY P M, LIU K D, BROPHY P D, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury[J]. Am J Kidney Dis,2013,61(5):649-672.doi:10.1053/j.ajkd.2013.02.349 .
doi: 10.1053/j.ajkd.2013.02.349
|
| [8] |
TV L, DL H, BL G, et al. Applicability of the Schwartz Equation and the Chronic Kidney Disease in Children Bedside Equation for Estimating Glomerular Filtration Rate in Overweight Children[J].Pharmacotherapy,2016,36(6):598-606.doi:10.1002/phar.1763 .
doi: 10.1002/phar.1763
|
| [9] |
SOLIMAN N A, ALI R I, GHOBRIAL E E, et al. Pattern of clinical presentation of congenital anomalies of the kidney and urinary tract among infants and children[J]. Nephrology (Carlton),2015,20(6):413-418.doi:10.1111/nep.12414 .
doi: 10.1111/nep.12414
|
| [10] |
CHEVALIER R L. CAKUT: A Pediatric and Evolutionary Perspective on the Leading Cause of CKD in Childhood[J]. Pediatr Rep,2023,15(1):143-153.doi:10.3390/pediatric15010012 .
doi: 10.3390/pediatric15010012
|
| [11] |
MATSELL D G, CATAPANG M, BECKNELL B. Predicting outcomes in children with congenital anomalies of the kidney and urinary tract[J]. Pediatr Nephrol,2023,38(10):3407-3415.doi:10.1007/s00467-023-05992-0 .
doi: 10.1007/s00467-023-05992-0
|
| [12] |
VASCONCELOS M A, E S A, GOMES I R, et al. A clinical predictive model of chronic kidney disease in children with posterior urethral valves[J]. Pediatr Nephrol,2019,34(2):283-294.doi:10.1007/s00467-018-4078-0 .
doi: 10.1007/s00467-018-4078-0
|
| [13] |
SHIRAZI M, CIANFARINI C, ISMAIL A, et al. Altered kidney distribution and loss of ACE2 into the urine in acute kidney injury[J]. Am J Physiol Renal Physiol,2024,327(3):F412-F425. doi:10.1152/ajprenal.00237.2023 .
doi: 10.1152/ajprenal.00237.2023
|
| [14] |
ZHENG J, HAO H. Targeting renal damage: The ACE2/Ang-(1-7)/mas axis in chronic kidney disease[J]. Cell Signal,2024,124:111413.doi:10.1016/j.cellsig.2024.111413 .
doi: 10.1016/j.cellsig.2024.111413
|
| [15] |
DANIEL B, LUISE H, JAN W. ACE2, From the Kidney to SARS-CoV-2: Donald Seldin Award Lecture 2023[J]. Hypertension (Dallas, Tex. : 1979),2025,82(2):166-180. doi:10.1161/HYPERTENSIONAHA.124.22064 .
doi: 10.1161/HYPERTENSIONAHA.124.22064
|
| [16] |
马雪晴, 何永华, 杨静, 等. 中国儿童PAX2基因突变的临床表型和基因型分析[J]. 中华肾脏病杂志,2024,40(1):24-35.doi:10.3760/cma.j.cn441217-20230518-00520 .
doi: 10.3760/cma.j.cn441217-20230518-00520
|
| [17] |
KLOMP L S, LEVTCHENKO E, WESTLAND R. Developmental Causes of Focal Segmental Glomerulosclerosis[J]. Glomerular Dis,2024,4(1):95-104.
|
| [18] |
马江磊, 张慧杰, 王光明. PAX2基因变异所致慢性肾脏病一个家系的遗传学分析[J]. 中华医学遗传学杂志,2023,40(8):973-978.doi:10.3760/cma.j.cn511374-20220801-00527 .
doi: 10.3760/cma.j.cn511374-20220801-00527
|
| [19] |
YAMAMURA Y, FURUICHI K, MURAKAWA Y, et al. Identification of candidate PAX2-regulated genes implicated in human kidney development[J]. Sci Rep,2021,11(1):9123.doi:10.1038/s41598-021-88743-1 .
doi: 10.1038/s41598-021-88743-1
|
| [20] |
李丽, 王长山. PAX2和 Ecadherin/a SMA在肾间质纤维化大鼠肾小管上皮共表达的作用及意义[J]. 国际免疫学杂志,2020,43(6):634-641.doi:10.3760/cma.j.issn.1673-4394.2020.06.006 .
doi: 10.3760/cma.j.issn.1673-4394.2020.06.006
|
| [21] |
李丽, 吴玉斌, 康晓明, 等. PAX2-siRNA在梗阻性肾病大鼠体内的作用研究[J]. 国际免疫学杂志,2016,39(4):348-353.doi:10.3760/cma.j.issn.1673-4394.2016.04.008 .
doi: 10.3760/cma.j.issn.1673-4394.2016.04.008
|
| [22] |
BEAMISH J A, TELANG A C, Mcelliott M C, et al. Pax protein depletion in proximal tubules triggers conserved mechanisms of resistance to acute ischemic kidney injury preventing transition to chronic kidney disease[J]. Kidney Int,2024,105(2):312-327.doi:10.1016/j.kint.2023.10.022 .
doi: 10.1016/j.kint.2023.10.022
|
| [23] |
UENO A, ONISHI Y, MISE K, et al. Plasma angiotensin-converting enzyme 2 (ACE2) is a marker for renal outcome of diabetic kidney disease (DKD) (U-CARE study 3)[J]. BMJ Open Diabetes Res Care,2024,12(3):e004237.doi:10.1136/bmjdrc-2024-004237 .
doi: 10.1136/bmjdrc-2024-004237
|
| [24] |
ANAND S, BAJPAI M, KHANNA T, et al. Urinary biomarkers as point-of-care tests for predicting progressive deterioration of kidney function in congenital anomalies of kidney and urinary tract: Trefoil family factors (TFFs) as the emerging biomarkers[J]. Pediatr Nephrol,2021,36(6):1465-1472.doi:10.1007/s00467-020-04841-8 .
doi: 10.1007/s00467-020-04841-8
|